Company news

Pharma Mar SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pharma Mar: Consolidated Financial Statements and Consolidated Directors' Report (Consolidated Financial Statements and Consolidated Directors)

March 13, 2026

Press Release (PR PhM Results FY2025 final 1)

February 27, 2026

PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer

June 3, 2025

Annual Report (ANNUAL REPORT 2024)

April 24, 2025

Separate Financial Statements (SEPARATE FINANCIAL STATEMENTS 2024)

April 24, 2025

Annual Report (ANNUAL REPORT PHARMAMAR 1)

March 18, 2025

PharmaMar estará presente en la 17ª edición de la European Large &MidCap event que se celebra en Paris

October 3, 2017

Calls

Decks

The 5 newest of 18 decks. Every deck is listed under its year.